Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ellmen, J; Werner, D; Hakulinen, P; Keiling, R; Fargeot, P; Falkson, G; Bezwoda, WR
   Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   J. Ellmen et al., "Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients", CANC CHEMOT, 45(5), 2000, pp. 402-408
2. Komi, J; Lassila, O
   Toremifene increases the expression of intercellular adhesion molecule-1 (ICAM-1) on MCF-7 breast cancer cells and Jurkat cells
   SCANDINAVIAN JOURNAL OF IMMUNOLOGY
   
   J. Komi e O. Lassila, "Toremifene increases the expression of intercellular adhesion molecule-1 (ICAM-1) on MCF-7 breast cancer cells and Jurkat cells", SC J IMMUN, 51(1), 2000, pp. 73-78
3. TOMAS E
   TOREMIFENE AND THE UTERUS
   European journal of cancer
   
   E. Tomas, "TOREMIFENE AND THE UTERUS", European journal of cancer, 34, 1998, pp. 58-59
4. TOMINAGA T; NOMURA Y; UCHINO J; HIRATA K; KIMURA M; YOSHIDA M; AOYAMA H; KINOSHITA H; KOYAMA H; MONDEN Y; TAKASHIMA S; OGAWA M
   CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUOROURACIL AND HIGH-DOSE TOREMIFENEFOR PATIENTS WITH ADVANCED RECURRENT BREAST-CANCER/
   Japanese Journal of Clinical Oncology
   
   T. Tominaga et al., "CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUOROURACIL AND HIGH-DOSE TOREMIFENEFOR PATIENTS WITH ADVANCED RECURRENT BREAST-CANCER/", Japanese Journal of Clinical Oncology, 28(4), 1998, pp. 250-254
5. MAENPAA JU; ALAFOSSI SL
   TOREMIFENE IN POSTMENOPAUSAL BREAST-CANCER - EFFICACY, SAFETY AND COST
   Drugs & aging
   
   J.U. Maenpaa e S.L. Alafossi, "TOREMIFENE IN POSTMENOPAUSAL BREAST-CANCER - EFFICACY, SAFETY AND COST", Drugs & aging, 11(4), 1997, pp. 261-270
6. BARAL E; NAGY E; KANGAS L; BERCZI I
   COMBINATION THERAPY OF THE H2712 MURINE MAMMARY-CARCINOMA WITH CYTOTOXIC T-LYMPHOCYTES AND ANTIESTROGENS
   Anticancer research
   
   E. Baral et al., "COMBINATION THERAPY OF THE H2712 MURINE MAMMARY-CARCINOMA WITH CYTOTOXIC T-LYMPHOCYTES AND ANTIESTROGENS", Anticancer research, 17(5A), 1997, pp. 3647-3651
7. BARAL E; NAGY E; KANGAS L; BERCZI I
   COMBINATION IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA WITH KILLER-CELLS, IL-2 AND ANTIESTROGENS
   Anticancer research
   
   E. Baral et al., "COMBINATION IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA WITH KILLER-CELLS, IL-2 AND ANTIESTROGENS", Anticancer research, 17(5A), 1997, pp. 3653-3658
8. NAGY E; BARAL E; KANGAS L; BERCZI I
   ANTIESTROGENS POTENTIATE THE IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA BY CYTOTOXIC T-LYMPHOCYTES
   Anticancer research
   
   E. Nagy et al., "ANTIESTROGENS POTENTIATE THE IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA BY CYTOTOXIC T-LYMPHOCYTES", Anticancer research, 17(2A), 1997, pp. 1083-1088
9. WISEMAN LR; GOA KL
   TOREMIFENE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF ADVANCED BREAST-CANCER
   Drugs
   
   L.R. Wiseman e K.L. Goa, "TOREMIFENE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF ADVANCED BREAST-CANCER", Drugs, 54(1), 1997, pp. 141-160
10. PYRHONEN S; VALAVAARA R; MODIG H; PAWLICKI M; PIENKOWSKI T; GUNDERSEN S; BAUER J; WESTMAN G; LUNDGREN S; BIANCO G; MELLA O; NILSSON I; HIETANEN T; HINDY I; VUORINEN J; HAJBA A
    COMPARISON OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A RANDOMIZED DOUBLE-BLIND, THE NORDIC PHASE-III STUDY
    British Journal of Cancer
    
    S. Pyrhonen et al., "COMPARISON OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A RANDOMIZED DOUBLE-BLIND, THE NORDIC PHASE-III STUDY", British Journal of Cancer, 76(2), 1997, pp. 270-277
11. HAYES DF; VANZYL JA; HACKING A; GOEDHALS L; BEZWODA WR; MAILLIARD JA; JONES SE; VOGEL CL; BERRIS RF; SHEMANO I; SCHOENFELDER J
    RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER
    Journal of clinical oncology
    
    D.F. Hayes et al., "RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER", Journal of clinical oncology, 13(10), 1995, pp. 2556-2566
12. HUOVINEN RL; ALANEN KA; COLLAN YU
    CELL-PROLIFERATION IN DIMETHYLBENZ(A)ANTHRACENE(DMBA)-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH ANTIESTROGEN TOREMIFENE
    Acta oncologica
    
    R.L. Huovinen et al., "CELL-PROLIFERATION IN DIMETHYLBENZ(A)ANTHRACENE(DMBA)-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH ANTIESTROGEN TOREMIFENE", Acta oncologica, 34(4), 1995, pp. 479-485
13. PERRY JJ; BERRY DA; WEISS RB; HAYES DM; DUGGAN DB; HENDERSON IC
    HIGH-DOSE TOREMIFENE FOR ESTROGEN AND PROGESTERONE-RECEPTOR NEGATIVE METASTATIC BREAST-CANCER - A PHASE-II TRIAL OF THE CANCER AND LEUKEMIAGROUP-B (CALGB)
    Breast cancer research and treatment
    
    J.J. Perry et al., "HIGH-DOSE TOREMIFENE FOR ESTROGEN AND PROGESTERONE-RECEPTOR NEGATIVE METASTATIC BREAST-CANCER - A PHASE-II TRIAL OF THE CANCER AND LEUKEMIAGROUP-B (CALGB)", Breast cancer research and treatment, 36(1), 1995, pp. 35-40
14. DRAGAN YP; VAUGHAN J; JORDAN VC; PITOT HC
    COMPARISON OF THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON LIVER AND KIDNEY TUMOR PROMOTION IN FEMALE RATS
    Carcinogenesis
    
    Y.P. Dragan et al., "COMPARISON OF THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON LIVER AND KIDNEY TUMOR PROMOTION IN FEMALE RATS", Carcinogenesis, 16(11), 1995, pp. 2733-2741
15. TOMAS E; KAUPPILA A; BLANCO G; APAJASARKKINEN M; LAATIKAINEN T
    COMPARISON BETWEEN THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON THE UTERUS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
    Gynecologic oncology
    
    E. Tomas et al., "COMPARISON BETWEEN THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON THE UTERUS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS", Gynecologic oncology, 59(2), 1995, pp. 261-266
16. HUOVINEN R; COLLAN Y
    CELL LOSS IN DIMETHYLBENZ(A)ANTHRACENE-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH TOREMIFENE AND OVARIECTOMY
    Tumor biology
    
    R. Huovinen e Y. Collan, "CELL LOSS IN DIMETHYLBENZ(A)ANTHRACENE-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH TOREMIFENE AND OVARIECTOMY", Tumor biology, 15(6), 1994, pp. 345-353
17. HUOVINEN R; KELLOKUMPULEHTINEN PLI; COLLAN Y
    EVALUATING THE RESPONSE TO ANTIESTROGEN TOREMIFENE TREATMENT IN DMBA INDUCED RAT MAMMARY-CARCINOMA
    International journal of experimental pathology
    
    R. Huovinen et al., "EVALUATING THE RESPONSE TO ANTIESTROGEN TOREMIFENE TREATMENT IN DMBA INDUCED RAT MAMMARY-CARCINOMA", International journal of experimental pathology, 75(4), 1994, pp. 257-263
18. SZAMEL I; HINDY I; VINCZE B; ECKHARDT S; KANGAS L; HAJBA A
    INFLUENCE OF TOREMIFENE ON THE ENDOCRINE REGULATION IN BREAST-CANCER PATIENTS
    European journal of cancer
    
    I. Szamel et al., "INFLUENCE OF TOREMIFENE ON THE ENDOCRINE REGULATION IN BREAST-CANCER PATIENTS", European journal of cancer, 30A(2), 1994, pp. 154-158
19. BIEDERMANN E; LOSER R; HASMANN M
    DROLOXIFENE INHIBITS GROWTH AND PROTEIN-S YNTHESIS OF BREAST-CANCER CELLS MORE EFFECTIVELY THAN TAMOXIFEN AND TOREMIFEN
    Onkologie
    
    E. Biedermann et al., "DROLOXIFENE INHIBITS GROWTH AND PROTEIN-S YNTHESIS OF BREAST-CANCER CELLS MORE EFFECTIVELY THAN TAMOXIFEN AND TOREMIFEN", Onkologie, 17, 1994, pp. 17-21
20. YANG DJ; LI C; KUANG LR; PRICE JE; BUZDAR AU; TANSEY W; CHERIF A; GRETZER M; KIM EE; WALLACE S
    IMAGING, BIODISTRIBUTION AND THERAPY POTENTIAL OF HALOGENATED TAMOXIFEN ANALOGS
    Life sciences
    
    D.J. Yang et al., "IMAGING, BIODISTRIBUTION AND THERAPY POTENTIAL OF HALOGENATED TAMOXIFEN ANALOGS", Life sciences, 55(1), 1994, pp. 53-67
21. IINO Y; TAKAI Y; ANDO T; SUGAMATA N; MAEMURA M; TAKEO T; OHWADA S; MORISHITA Y
    EFFECT OF TOREMIFENE ON THE GROWTH, HORMONE RECEPTORS AND INSULIN-LIKE GROWTH FACTOR-I OF HORMONE-DEPENDENT MCF-7 TUMORS IN ATHYMIC MICE
    Cancer chemotherapy and pharmacology
    
    Y. Iino et al., "EFFECT OF TOREMIFENE ON THE GROWTH, HORMONE RECEPTORS AND INSULIN-LIKE GROWTH FACTOR-I OF HORMONE-DEPENDENT MCF-7 TUMORS IN ATHYMIC MICE", Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 353-358
22. STENBYGAARD LE; HERRSTEDT J; THOMSEN JF; SVENDSEN KR; ENGELHOLM SA; DOMBERNOWSKY P
    TOREMIFENE AND TAMOXIFEN IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND CROSS-OVER TRIAL
    Breast cancer research and treatment
    
    L.E. Stenbygaard et al., "TOREMIFENE AND TAMOXIFEN IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND CROSS-OVER TRIAL", Breast cancer research and treatment, 25(1), 1993, pp. 57-63